Common variants at 19p13 are associated with susceptibility to ovarian cancer.
about
Imputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerGenomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical PracticeNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskLamina-associated polypeptide (LAP)2α and other LEM proteins in cancer biologyDNA methylation changes in epithelial ovarian cancer histotypes.Targeted immune therapy of ovarian cancerMutations in BRIP1 confer high risk of ovarian cancerContribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationClinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesThe GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse HematopoiesisIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.Ovarian cancer epidemiology in the era of collaborative team science.Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAssessing the genetic architecture of epithelial ovarian cancer histological subtypes.Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patientsHereditary breast cancer: ever more pieces to the polygenic puzzle.Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk.Prediction of potential cancer-risk regions based on transcriptome data: towards a comprehensive viewThe NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.Functional annotation signatures of disease susceptibility loci improve SNP association analysis.Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.Analyzing association of the XRCC3 gene polymorphism with ovarian cancer risk.Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerThe contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.Genetic variants in TGF-β pathway are associated with ovarian cancer risk.Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development.Reproducibility and concordance of differential DNA methylation and gene expression in cancer.Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.Evidence of differential effects of vitamin d receptor variants on epithelial ovarian cancer risk by predicted vitamin d status.Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer.Associations between gene expression variations and ovarian cancer risk alleles identified from genome wide association studies
P2860
Q23924183-256663E5-312A-44DF-B7D6-7357C6141299Q24633316-E37335F5-381B-47FD-ACAD-9E52F7323025Q26740622-4BFF940F-B260-4C84-85B4-13A5C6AF10E3Q26799669-42010FF8-CC5C-41A1-9C50-821480082CE8Q27687804-FD713F1D-C79E-4FF4-9C33-B35C83020BBDQ27690722-965CF800-7A2B-450A-9829-CC6B12A17C41Q28082828-14169FD0-F7A4-4ECF-B93F-6C8A107A86C8Q28249514-56C940CA-ADA7-4F5C-AD5F-4263AB03FAD4Q28266112-4557F45D-CB6B-4EED-A765-B30D1666658AQ28307436-B80B708B-CE03-416F-A8DC-97AC75725A60Q28388497-AE16A055-D329-410A-89A4-8D003076C522Q28592466-095CA5A3-0E73-49CF-A846-EC7BA71EC376Q30252854-0AF3E150-DD3B-435E-B9D1-C94C118F4E06Q30252952-C2305B36-0282-4975-B743-8D7D979D0A8BQ30252987-3D4F630C-C837-4389-BCD0-31E2BB3A180FQ30275132-A01E95DF-D940-4527-91DA-2840E8B86F8AQ30276359-576554B9-ED63-4C99-9881-90A9B33A57A6Q30276986-A47C8C73-447D-49D6-83D9-6E47EC2BDDC1Q30277151-BD9DA272-361A-4DD8-A9C4-5EFC663B2F19Q30277784-33832738-EECF-4A76-AD70-5F30242E2A4EQ30612061-B1EEE2F5-FDE5-4984-9EB5-BB1A356C9AD5Q33356511-64D877CD-1722-4614-A935-B3261CE0FB73Q33565679-11120FF0-A990-4C0F-A099-757BDA51077AQ33567947-A858E3DF-312A-4922-B7B4-FF7574800659Q33688960-DCA621E9-3920-4EDA-95E4-006DDE06E5F0Q33701048-C14CFB7C-9764-4E91-977E-1ADA31E99AD0Q33778612-E4D1CCB4-1DE8-46BE-8C70-1A9250DE3697Q33810288-3DC95D55-6B08-41C4-8E88-8A57383A195FQ33810401-0ECF531A-BA47-4D84-9765-A7DA6BBFA2E0Q33847791-EA1BDB87-7441-46E1-B757-7F0E8D3D77EDQ33991747-3C14AA48-7798-420D-BD94-67CB6F768477Q34031757-72F11CD2-4774-46D3-BA56-4DEF0252264BQ34044950-3D44E134-13B1-428A-AE36-3BA35747CFBDQ34091855-54DB821A-55E7-44EA-A3E4-D47BB9F7EE4FQ34123835-43F867E0-97DD-46F7-9CD6-E4A493957F74Q34177267-D36A27F7-64BD-40C9-8833-4AA439CCEF07Q34342248-93DB0E35-8ECA-4F55-8D8C-115639F35BCFQ34368796-EDE9507F-A105-44A4-98C9-30C1833717B2Q34406374-9DAA9A85-6205-4A0F-B738-DBD69D8788C7Q34469596-4853A538-58A5-42D7-B14D-86E867C8753F
P2860
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
@ast
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
@en
type
label
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
@ast
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
@en
prefLabel
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
@ast
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
@en
P2093
Alice S Whittemore
Andrew Berchuck
Anne M van Altena
Arto Leminen
Australian Cancer Study (Ovarian Cancer)
Beth Y Karlan
Brooke L Fridley
Catherine Phelan
Celeste Leigh Pearce
P2507
P2860
P2888
P304
P3181
P356
10.1038/NG.666
P407
P50
P577
2010-09-19T00:00:00Z
P5875
P6179
1032733662